James R. Clark
Advanced in Migraine with Brainstem Aura

Dr. James R. Clark

Internal Medicine
701 Northpoint Pkwy Ste 140, 
West Palm Beach, FL 
Advanced in Migraine with Brainstem Aura
701 Northpoint Pkwy Ste 140, 
West Palm Beach, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Clark is a primary care provider, practicing in Internal Medicine in West Palm Beach, Florida. Dr. Clark is rated as an Advanced provider by MediFind in the treatment of Migraine with Brainstem Aura. His top areas of expertise are Familial Hemiplegic Migraine, Migraine with Brainstem Aura, Migraine, and Blood Clots.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 3 clinical trials in the study of Migraine with Brainstem Aura.

Specialties
Internal Medicine
Licenses
Internal Medicine in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 1 Less Insurance Carrier -

Locations

701 Northpoint Pkwy Ste 140, West Palm Beach, FL 33407
Other Locations
325 Winding River Ln Ste 102, Charlottesville, VA 22911

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Vestibular Nerve Stimulation (VeNS), Together with a Lifestyle Modification Program, Compared to a Sham Control with a Lifestyle Modification Program, As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Vestibular Nerve Stimulation (VeNS), Together with a Lifestyle Modification Program, Compared to a Sham Control with a Lifestyle Modification Program, As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Behavioral, Device
Study Phase: Not Applicable
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: March 28, 2024
Intervention Type: Drug
Study Drug: X0002
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

3 Total Publications

The acute effects of exercise intensity and inorganic nitrate supplementation on vascular health in females after menopause.
The acute effects of exercise intensity and inorganic nitrate supplementation on vascular health in females after menopause.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: October 05, 2023
Similar Doctors
Experienced in Migraine with Brainstem Aura
Dr. Mira Baron
Internal Medicine
Experienced in Migraine with Brainstem Aura
Dr. Mira Baron
Internal Medicine
2277 Palm Beach Lakes Blvd, 
West Palm Beach, FL 
 (3.4 miles away)
561-689-0606
Languages Spoken:
English
See accepted insurances

Mira Baron is a primary care provider, practicing in Internal Medicine in West Palm Beach, Florida. Dr. Baron is rated as an Experienced provider by MediFind in the treatment of Migraine with Brainstem Aura. Her top areas of expertise are Migraine with Brainstem Aura, Familial Hemiplegic Migraine, Migraine, and Parainfluenza.

Experienced in Migraine with Brainstem Aura
Dr. Carlos A. Vizcarra-Pa
Internal Medicine
Experienced in Migraine with Brainstem Aura
Dr. Carlos A. Vizcarra-Pa
Internal Medicine

Carlos A Vizcarra MD PA

13000 Us Hwy 1 4, 
Sebastian, FL 
 (4.0 miles away)
772-589-9188
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Carlos Vizcarra-Pa is a primary care provider, practicing in Internal Medicine in Sebastian, Florida. Dr. Vizcarra-Pa is rated as a Distinguished provider by MediFind in the treatment of Migraine with Brainstem Aura. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, Sitosterolemia, and Pacemaker Implantation. Dr. Vizcarra-Pa is currently accepting new patients.

Experienced in Migraine with Brainstem Aura
Dr. Minerva M. Ellis
Internal Medicine
Experienced in Migraine with Brainstem Aura
Dr. Minerva M. Ellis
Internal Medicine

Palm Beach Physicians Group Inc

4601 N Congress Ave, Suite 200, 
West Palm Bch, FL 
 (0.3 miles away)
561-840-4660
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Minerva Ellis is a primary care provider, practicing in Internal Medicine in West Palm Bch, Florida. Dr. Ellis is rated as an Advanced provider by MediFind in the treatment of Migraine with Brainstem Aura. Her top areas of expertise are Gardner-Diamond Syndrome, Autoerythrocyte Sensitivity, Purpura, and Cirrhosis. Dr. Ellis is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Clark's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile